Intrinsic Value
Regulus Therapeutics Inc. (RGLS)
$2.43
+0.16 (+7.05%)
| Enterprise Value | -2,589.56 |
|---|---|
| Net Debt | -20.73 |
| Equity Value | -2,568.83 |
| Shares Outstanding | 18.96 |
| Equity Value Per Share | -135.48 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt